Navigation Links
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Date:6/17/2009

Zipsor

Like all prescription non-steroidal anti-inflammatory drugs (NSAIDs), Zipsor may increase the chance of a heart attack or stroke that can lead to death. Zipsor should not be used right before or after certain heart surgeries. Serious skin reactions or stomach and intestine problems, such as bleeding and ulcers, can occur without warning and may cause death. Patients taking aspirin or other blood thinners and the elderly are at increased risk for stomach bleeding and ulcers. Tell your doctor about all of the medications you take and all of your medical conditions prior to taking Zipsor, especially if you are pregnant, have a history of ulcers or bleeding in the stomach or intestines, have high blood pressure or heart failure or heart disease, or have kidney or liver problems. People with aspirin-sensitive asthma or allergic reactions due to aspirin or other NSAIDs should not take Zipsor. Prescription Zipsor should be used exactly as prescribed at the lowest possible dose for the shortest time needed. For additional important information about Zipsor see the FDA-approved medication guide or the full prescribing information.

About Xanodyne

Xanodyne Pharmaceuticals, Inc., which commenced operations in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management. Xanodyne markets a portfolio of revenue generating products consisting of prescription pharmaceuticals and a line of prenatal vitamins. Additionally, Xanodyne is advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne's focus areas.


'/>"/>
SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Xanodyne Announces Appointment of Mr. Vaughn M. Kailian of MPM Capital to the Board of Directors
2. Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
3. Xanodynes New Drug Application for the Treatment of Heavy Menstrual Bleeding (Menorrhagia) Accepted for Filing with a Priority Review Classification
4. Epeius Biotechnologies Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
5. STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
6. Herzing University, Minneapolis Receives Board of Nursing Approval
7. Steelcase Inc. Receives Five Best of NeoCon Awards and Best Overall Showroom for Nurture at NeoCon 2009
8. President Obama Receives Warm Welcome from AMA Physicians
9. Biomerix Corporation Receives ISO 13485 Certification
10. Instrumentation Laboratory Receives 510(k) Clearance From FDA for HemosIL(R) Liquid Heparin Assay
11. Endologix Receives Nasdaq Letter on Director Independence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... new network of 25 regional stroke centers and satellite ... is working to change the way stroke research ... the last two decades, stroke remains a major public ... for 795,000 Americans. The numbers are expected to rise ... To accelerate the pace of progress, NIH StrokeNet brings ...
(Date:7/30/2014)... Over 630 doctors worldwide are now certified ... minimally invasive treatment for gum recession. Santa Barbara, CA ... peers to be the “father of microsurgery” in periodontics ... Pinhole Surgical Technique® training course at the Chao Pinhole ... of the American Academy of Periodontics (AAP) 2010 Master ...
(Date:7/30/2014)... Children’s Hospital of Michigan Foundation and Kohl’s ... p.m. to 7 p.m. Wednesday, August 6 at the ... MI 48152). The event will feature Detroit Red Wings ... snacks and local public safety officials. Kohl’s will present ... Michigan Foundation. , The gift supports Kohl’s Injury ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 ... China Chitosan Industry” is a professional and ... market. The report provides basic Chitosan information, ... chain structure as well as industry overview. ... China’s domestic market as well as global ...
(Date:7/30/2014)... By Amy Norton ... -- Spending time in a garden might help soothe the ... suggests. Looking at 17 past studies, British researchers found ... garden can help soothe some dementia patients, anxiety. The ... patients are a tough subject to study -- and the ...
Breaking Medicine News(10 mins):Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... health care recruiting and staffing. Individuals have the choice of starting ... with an established Health Career Agents office. , ... ... now has three ways for qualified individuals to get involved in ...
... Corporation (NYSE Alternext US: FIT), a leading provider of ... that Gregg Lehman, Ph.D., president and chief executive officer ... the B. Riley & Co., LLC,s 10th Annual Las ... 11:00 a.m. PT. The conference will be held at ...
... Inc. (NYSE Alternext: ULU) today announced the ... as Chairman of the Company,s Scientific Advisory Board.Currently, Dr. ... for Comprehensive Wound Care and Hyperbaric Oxygen Therapy, St. ... He also serves as the President and Chief Operating ...
... March 13 InterMune, Inc. (Nasdaq: ITMN ... Executive Officer and President of InterMune, will present at ... in Boston on March 17, 2009 at 3:10 p.m. ... investors and other interested parties may log on to ...
... MedQuist Inc. (Nasdaq: MEDQ ), a ... announce that it has resolved the investigation by the ... billing practices. Pursuant to the settlement, the Company ... litigation by the SEC, including an injunction against the ...
... U.S., expert says, , , FRIDAY, March 13 (HealthDay News) ... kidney disease, whether young or old, respond equally well ... passageways between veins and arteries to help in the ... fistulas the "gold standard of access for kidney dialysis ...
Cached Medicine News:Health News:Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing 2Health News:Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing 3Health News:ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board 2Health News:MedQuist Announces Resolution of SEC Investigation 2Health News:Dialysis Via Fistulas May Help Young or Old 2
(Date:7/30/2014)...  El Camino Hospital, a leader in the use ... Leaf Patient Monitoring system to help prevent hospital-acquired pressure ... susceptible to bed sores. The decision was ... the system, which showed dramatic improvement in compliance with ... the one of the most effect ways to prevent ...
(Date:7/30/2014)... YORK , July 30, 2014 ... is available in its catalogue: mHealth ... http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html Executive summary ... are delivered, leading to better outcomes, decreased costs ... market for mHealth solutions is still in an ...
(Date:7/30/2014)...  InnoPharma, Inc. today announced the first generic launch ... Zyprexa® injection), in Canada.  Olanzapine is indicated for the ... with schizophrenia or bipolar I mania. As ... entered into an agreement with Sandoz Canada Inc., pursuant ... sell, market and distribute Olanzapine Injection in ...
Breaking Medicine Technology:El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2
... 10 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) announced ... for March 13, 2008 at 10:00 a.m. ET to ... trial programs as,well as its business opportunities., Interested ... callers outside the U.S. may participate by dialing (201),689-8349 ...
... Gynecologic Oncologists, Annual ... Meeting on Women,s Cancer -, FREMONT, Calif. and ... molecular diagnostics company,presented data from several studies demonstrating the benefits of ... Vermillion,s biomarkers could help better identify women with ovarian,cancer, as well ...
Cached Medicine Technology:Access Pharmaceuticals to Conduct Conference Call to Update Financial Community 2Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 2Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 3Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 4Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 5
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... REA kit measures the biologically active form ... B6 is a valuable prognostic marker for ... low plasma vitamin B6 level and Coronary ... transamination reactions of homocysteine to cystathionine and ...
... for use with 4, 8, or 12 channel ... of nearly all of the solution. Corners have ... of natural virgin polystyrene containing no regrinds. Sterile ... irradiation. Dimensions: 78 mm W x 152 mm ...
Volume: 10 ml; Volume Graduation: 1/10 ml...
Medicine Products: